SI-Bone (SIBN) Price & Analysis

Compare

177 Followers

SIBN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$11.70 - $20.05

Previous CloseN/A

Volume50.81K

Average Volume (3M)444.40K

Market Cap

$653.15M

Enterprise Value$696.66M

Total Cash (Recent Filing)$144.41M

Total Debt (Recent Filing)$37.15M

Price to Earnings (P/E)―

Beta0.83

Next Earnings

Nov 10, 2025

EPS Estimate

-0.17

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.14

Shares Outstanding43,140,938

10 Day Avg. Volume360,815

30 Day Avg. Volume444,400

Financial Highlights & Ratios

PEG Ratio0.56

Price to Book (P/B)3.48

Price to Sales (P/S)3.48

P/FCF Ratio-25.36

Enterprise Value/Market Cap1.07

Enterprise Value/Revenue3.94

Enterprise Value/Gross Profit4.98

Enterprise Value/Ebitda-37.13

Forecast

1Y Price Target

$24.60

Price Target Upside62.91% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSI-BONE management was pleased with their performance and the fact that all three business segments are growing double-digits.

Sales PotentialManagement believes hitting half a billion in sales is achievable through continued innovation, strong clinical evidence, improving reimbursement, and further surgeon penetration.

Bears Say

Market PenetrationSIBN estimates a combined TAM of nearly $4B, yet noted given its most recent guide currently only penetrates this TAM by ~5%, emphasizing the significant growth opportunity.

SI-Bone News

SI-Bone’s Strong Performance and Strategic Initiatives Justify Buy Rating

In a report released yesterday, Patrick Wood from Morgan Stanley maintained a Buy rating on SI-Bone, with a...

8d ago

SIBN

Si-Bone’s Earnings Call Highlights Strong Growth and Future Prospects

Si-Bone (($SIBN)) has held its Q2 earnings call. Read on for the main highlights of the call. The...

1M ago

SIBN

SI-Bone’s Promising Financial Trajectory and Growth Potential Underpin Buy Rating

Analyst David Saxon from Needham reiterated a Buy rating on SI-Bone and keeping the price target at $24.00....

1M ago

SIBN

SI-BONE Reports Strong Q2 Growth and Raises Guidance

Si-Bone ( ($SIBN) ) has released its Q2 earnings. Here is a breakdown of the information Si-Bone presented...

1M ago

SIBN

SI-Bone reports Q2 EPS (14c), consensus (18c)

Reports Q2 revenue $48.63M, consensus $48.12M. “Our strong second-quarter performance highlights how our innovation-driven strategy continues to fuel...

1M ago

SIBN

SI-Bone raises FY25 revenue view to $195M-$198M from $193.5M-$197.5M

Consensus $195.98M. Sees FY25 adjusted EBITDA positive. Sees FY25 gross margin 78.5%-79%. The company said, “SI-BONE (SIBN) expects...

1M ago

SIBN

SI-Bone Reports Strong Q2 2025 Financial Results

The latest update is out from SI-Bone ( ($SIBN) ). On August 4, 2025, SI-BONE announced the retirement...

1M ago

SIBN

Si-Bone (SIBN) Q2 Earnings Cheat Sheet

Si-Bone (SIBN) is scheduled to report 2nd quarter earnings on 08/04/2025, after the market closes. Regarding Q2 estimates,...

2M ago

SIBN

SI-Bone Concludes Annual Meeting with Key Approvals

SI-Bone ( ($SIBN) ) has provided an update. On April 7, 2025, SI-Bone held its Annual Meeting with...

3M ago

SIBN

Needham medtech & diagnostics analyst holds analyst/industry conference call

Med Tech & Diagnostics Analyst Saxon discusses spinal implants, enabling technologies, spinal cord stimulation, and the potential impact...

4M ago

JNJ

MDT

SI-BONE Earnings Call: Strong Growth Amid Challenges

Si-Bone (($SIBN)) has held its Q1 earnings call. Read on for the main highlights of the call. The...

4M ago

SIBN

SI-Bone management to meet with Cantor Fitzgerald

Meeting to be held in London, England on May 8 hosted by Cantor Fitzgerald. Published first on TheFly...

4M ago

SIBN

SI-Bone price target raised to $22 from $20 at Truist

Truist raised the firm’s price target on SI-Bone (SIBN) to $22 from $20 and keeps a Buy rating...

5M ago

SIBN

SI-Bone’s Strong Performance and Growth Potential Reinforce Buy Rating

Analyst Kallum Titchmarsh of Morgan Stanley reiterated a Buy rating on SI-Bone (SIBN – Research Report), retaining the...

5M ago

SIBN

SIBN FAQ

What was SI-Bone Inc’s price range in the past 12 months?

SI-Bone Inc lowest stock price was $11.70 and its highest was $20.05 in the past 12 months.

What is SI-Bone Inc’s market cap?

SI-Bone Inc’s market cap is $653.15M.

When is SI-Bone Inc’s upcoming earnings report date?

SI-Bone Inc’s upcoming earnings report date is Nov 10, 2025 which is in 53 days.

How were SI-Bone Inc’s earnings last quarter?

SI-Bone Inc released its earnings results on Aug 04, 2025. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.183 by $0.043.

Is SI-Bone Inc overvalued?

According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does SI-Bone Inc pay dividends?

SI-Bone Inc does not currently pay dividends.

What is SI-Bone Inc’s EPS estimate?

SI-Bone Inc’s EPS estimate is -0.17.

How many shares outstanding does SI-Bone Inc have?

SI-Bone Inc has 43,140,938 shares outstanding.

What happened to SI-Bone Inc’s price movement after its last earnings report?

SI-Bone Inc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.183. Following the earnings report the stock price went down -10.615%.

Which hedge fund is a major shareholder of SI-Bone Inc?

Currently, no hedge funds are holding shares in SIBN

SI-Bone Stock Smart Score

Underperform

Fundamentals

Return on Equity

-14.18%

Trailing 12-Months

Asset Growth

3.16%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

SI-Bone Inc

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

SI-Bone (SIBN) Earnings & Revenues

Historic Earnings Reports

SIBN Company Deck

SIBN Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

SI-BONE's earnings call highlighted strong revenue growth, improved profitability, and successful market expansion, despite some regulatory delays in Europe and continued net losses. The positive performance significantly outweighs the challenges faced.View all SIBN earnings summaries

SIBN Stock 12 Month Forecast

Average Price Target

$24.60

▲(62.91% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","29":"$29","16.25":"$16.25","20.5":"$20.5","24.75":"$24.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.25,20.5,24.75,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.45,17.338461538461537,18.226923076923075,19.115384615384613,20.003846153846155,20.892307692307693,21.78076923076923,22.66923076923077,23.557692307692307,24.446153846153848,25.334615384615383,26.223076923076924,27.111538461538462,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.45,17.076923076923077,17.703846153846154,18.33076923076923,18.95769230769231,19.584615384615386,20.211538461538463,20.838461538461537,21.465384615384615,22.092307692307692,22.71923076923077,23.346153846153847,23.973076923076924,{"y":24.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.45,16.723076923076924,16.996153846153845,17.26923076923077,17.54230769230769,17.815384615384616,18.088461538461537,18.361538461538462,18.634615384615383,18.907692307692308,19.18076923076923,19.453846153846154,19.726923076923075,{"y":20,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.62,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.49,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.37,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.02,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.76,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.04,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.68,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.86,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.39,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.45,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >